Traditional Chinese medicine for COVID-19 pandemic and emerging challenges: An online cross-sectional survey in China.
COVID-19
Mental health
Online survey
Respiratory symptoms
Traditional Chinese medicine
Journal
Integrative medicine research
ISSN: 2213-4220
Titre abrégé: Integr Med Res
Pays: Netherlands
ID NLM: 101612707
Informations de publication
Date de publication:
2021
2021
Historique:
received:
13
09
2021
revised:
07
10
2021
accepted:
08
10
2021
pubmed:
26
10
2021
medline:
26
10
2021
entrez:
25
10
2021
Statut:
ppublish
Résumé
We aimed to investigate use of infection control behaviours, preventative and therapeutic interventions, and outcomes among respondents to an online survey during the COVID-19 pandemic in China. The survey was designed by an international team, translated and adapted to simplified Chinese, including 132 kinds of traditional Chinese medicine (TCM) preparation recommended by guidelines. It was distributed and collected from February to May 2021, with data analysed by WPS spreadsheet and The survey was accessed 503 times with 341 (67.8%) completions covering 23 provinces and four municipalities in China. Most (282/341, 82.7%) respondents reported no symptoms during the pandemic and the majority (290/341, 85.0%) reported having a SARS-CoV-2 PCR test at some point. Forty-five (13.2%) reported having a respiratory infection, among which 19 (42.2%) took one or more categories of modern medicine, e.g. painkillers, antibiotics; 16 (35.6%) used TCM interventions(s); while seven respondents combined TCM with modern medicine. All respondents reported using at least one behavioural or medical approach to prevention, with 22.3% taking TCM and 5.3% taking modern medicines. No respondents reported having a critical condition related to COVID-19. We found evidence of widespread use of infection control behaviours, modern medicines and TCM for treatment and prevention of COVID-19 and other respiratory symptoms. Larger scale studies are warranted, including a more representative sample exploring TCM preparations recommended in clinical guidelines.
Sections du résumé
BACKGROUND
BACKGROUND
We aimed to investigate use of infection control behaviours, preventative and therapeutic interventions, and outcomes among respondents to an online survey during the COVID-19 pandemic in China.
METHODS
METHODS
The survey was designed by an international team, translated and adapted to simplified Chinese, including 132 kinds of traditional Chinese medicine (TCM) preparation recommended by guidelines. It was distributed and collected from February to May 2021, with data analysed by WPS spreadsheet and
RESULTS
RESULTS
The survey was accessed 503 times with 341 (67.8%) completions covering 23 provinces and four municipalities in China. Most (282/341, 82.7%) respondents reported no symptoms during the pandemic and the majority (290/341, 85.0%) reported having a SARS-CoV-2 PCR test at some point. Forty-five (13.2%) reported having a respiratory infection, among which 19 (42.2%) took one or more categories of modern medicine, e.g. painkillers, antibiotics; 16 (35.6%) used TCM interventions(s); while seven respondents combined TCM with modern medicine. All respondents reported using at least one behavioural or medical approach to prevention, with 22.3% taking TCM and 5.3% taking modern medicines. No respondents reported having a critical condition related to COVID-19.
CONCLUSION
CONCLUSIONS
We found evidence of widespread use of infection control behaviours, modern medicines and TCM for treatment and prevention of COVID-19 and other respiratory symptoms. Larger scale studies are warranted, including a more representative sample exploring TCM preparations recommended in clinical guidelines.
Identifiants
pubmed: 34692409
doi: 10.1016/j.imr.2021.100798
pii: S2213-4220(21)00085-8
pmc: PMC8524811
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100798Informations de copyright
© 2021 Korea Institute of Oriental Medicine. Published by Elsevier B.V.
Déclaration de conflit d'intérêts
The authors declare that there is no conflict of interest regarding the publication of this article.
Références
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Cochrane Database Syst Rev. 2020 Sep 15;9:CD013574
pubmed: 33959956
J Obstet Gynaecol Res. 2020 Oct;46(10):1958-1966
pubmed: 32779342
Lancet. 2020 Mar 7;395(10226):809-815
pubmed: 32151335
Eur J Clin Nutr. 2020 Jun;74(6):871-875
pubmed: 32322046
J Infect Dev Ctries. 2020 Dec 31;14(12):1374-1379
pubmed: 33378278
Lancet. 2020 Jun 13;395(10240):1845-1854
pubmed: 32450106
Cochrane Database Syst Rev. 2021 Feb 12;2:CD013587
pubmed: 33624299
Transl Pediatr. 2020 Feb;9(1):51-60
pubmed: 32154135
Lancet. 2020 Jun 13;395(10240):1820
pubmed: 32511943
Otolaryngol Head Neck Surg. 2020 Jul;163(1):170-178
pubmed: 32423368
N Engl J Med. 2021 Feb 11;384(6):497-511
pubmed: 33264556
JAMA. 2020 Sep 8;324(10):951-960
pubmed: 32789505
J Biomed Sci. 2020 Dec 20;27(1):104
pubmed: 33341119
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Lancet Infect Dis. 2021 Aug;21(8):1107-1119
pubmed: 33773111
Int J Gynaecol Obstet. 2020 Oct;151(1):154-156
pubmed: 32644220
Front Pharmacol. 2021 Aug 06;12:609213
pubmed: 34421581
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
BMJ Open. 2021 Jun 24;11(6):e048416
pubmed: 34168031
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Lancet Infect Dis. 2021 Jun;21(6):803-812
pubmed: 33548194
Chin J Integr Med. 2020 Apr;26(4):243-250
pubmed: 32065348
Rev Inst Med Trop Sao Paulo. 2020;62:e62
pubmed: 32876296
Pharmacol Res. 2020 May;155:104768
pubmed: 32222346
Lancet Infect Dis. 2021 Jan;21(1):39-51
pubmed: 33069281
BMC Med. 2021 Jul 28;19(1):173
pubmed: 34315454
J Med Internet Res. 2004 Sep 29;6(3):e34
pubmed: 15471760
J Affect Disord. 2021 Sep 1;292:172-188
pubmed: 34126309
Value Health. 2011 Dec;14(8):1101-8
pubmed: 22152180
Lancet Infect Dis. 2021 Feb;21(2):181-192
pubmed: 33217362
Asian J Psychiatr. 2020 Aug;52:102066
pubmed: 32302935
Lancet. 2021 Oct 9;398(10308):1377-1380
pubmed: 34534516
Transl Psychiatry. 2020 Oct 19;10(1):355
pubmed: 33077738
Br J Haematol. 2020 Jul;190(1):e37-e38
pubmed: 32420614
Pharmacol Ther. 2021 Sep;225:107843
pubmed: 33811957